Artificial Intelligence

Artificial Intelligence(AI) already on the move in Africa

Artificial Intelligence(AI) is when a machine mimics “cognitive” functions of humans associate with other human minds, as machines become increasingly capable of thinking in this decade.

Sophia Genetics a Data-Driven Medicine pioneer made known in their 2017 Annual Meeting of the American College of Medical Genetics and Genomics (ACMG) in Phoenix, the list of African hospitals enrolled in the integration of  SOPHiA, the company’s artificial intelligence, into their clinical workflow to advance patients’ care on the continent.

Medical institutions innovating with the AI on the continent include:

  • PharmaProcess in Casablanca, Morocco;
  • ImmCell in Rabat, Morocco;
  • The Al Azhar Oncology Center in Rabat, Morocco;
  • The Riad Biology Center in Rabat, Morocco;
  • The Oudayas, Medical Analysis Laboratory, Morocco;
  • The Center for Proteomic & Genomic Research (CPGR) in Cape Town, South Africa;
  • The Bonassama District Hospital in Douala, Cameroon.

SOPHiA is the most advanced artificial intelligence AI for Data-Driven Medicine. A state-of-the-art technology, SOPHiA continuously learns from thousands of patients genomic profiles and experts’ knowledge to improve patients diagnostics and treatments.

SOPHiA is helping  by making use of its knowledge base in making diagnostics faster than ever. The seven medical facilities has become part of a larger network of 260 hospitals in 46 countries that share clinical insights across patient cases and populations and feeding the knowledge base of biomedical findings.

Sophia DDM®,  the platform for clinicians to perform routine diagnostic testing whic have at its core PEPPER™, MUSKAT™ and MOKA™ from SOPHiA™ – the most advanced artificial intelligence for Data-Driven Medicine. 

SOPHiA™ process and analyses raw genomic data to help hospitals  diagnose patients across a broad range of diseases including oncology, metabolism, pediatrics, cardiology and hereditary cancers better and faster.

“With such advanced and cost-effective DNA sequence analysis technology, clinicians are unlocking a new era of personalized medicine where patients can be diagnosed faster and more accurately”.

Professor Miguel Angel Moreno-Pelayo, Head of Genetics at the Hospital Ramón y Cajal, Madrid